Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy

Recently, the emergence of immunotherapy has revolutionized traditional tumour treatment. However, effective treatments for patients exhibiting αPD-1 resistance are still lacking. In our study, a combination of cytosine–phosphate–guanine oligodeoxynucleotides (CpG-ODNs), anti-OX40 and cyclic guanosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Luya, Du, Xuedan, Zhang, Cheng, Yu, Shanshan, Liu, Lixiao, Zhao, Jinduo, Zhao, Ye, Zhang, Chunhong, Wu, Jinting, Wang, Bin, Chen, Yingyu, Su, Xiaoping, Yan, Xiaojian, Li, Wenfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188536/
https://www.ncbi.nlm.nih.gov/pubmed/34731284
http://dx.doi.org/10.1007/s00262-021-03095-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188536/
https://www.ncbi.nlm.nih.gov/pubmed/34731284
http://dx.doi.org/10.1007/s00262-021-03095-z

Ejemplares similares